Abstract
s S91 (SFN) by i.p. 1 day prior to surgery to induce Nrf2, with saline as vehicle control (n= 6 per group). After 2 hours of cold ischemia, donor hearts were transplanted into the recipients. Just after transplant, recipients received an additional single injection of SFN or saline. Following 24 hours of reperfusion, echocardiography was performed and donor hearts were harvested. Superoxide dismutase-2 (SOD2) and Caspase-3 activities were measured as markers of the Nrf2 pathway downstream enzyme and apoptosis respectively. P65 and phosphorylated P65 were measured by Western immunoblotting to assess NF-kB activation. Results: Compared to WT-Saline, KO-Saline demonstrated lower SOD2, increased Caspase-3, and increased P65 expression and phosphorylation. Among WT donors, SFN treatment rescued SOD2, decreased Caspase-3, and inhibited P65 phosphorylation compared to saline treatment. These SFN effects were absent on KO donors (Figure A). Echocardiography of donor hearts showed that the fractional area change (FAC) was significantly higher in WT-SFN than WT-Saline. KO-Saline and KO-SFN displayed similarly lower FAC than WT donors (Figure B). Conclusion: Our results suggest the anti-inflammatory potential of Nrf2 through inhibition of NF-kB activity during IRI. The Nrf2 pathway may be a promising pharmacological target to mitigate IRI-mediated inflammation, apoptosis, and impaired cardiac function through the anti-inflammatory property as well as its anti-oxidant nature in heart transplantation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.